Insider Transactions in Q2 2023 at Dexcom Inc (DXCM)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 23
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
412
-0.31%
|
$51,500
$125.92 P/Share
|
Jun 15
2023
|
Shelly Ramasamy Selvaraj SVP Chief Information Officer |
SELL
Open market or private sale
|
Direct |
2,115
-4.03%
|
$274,950
$130.0 P/Share
|
Jun 09
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
393
-0.47%
|
$47,553
$121.31 P/Share
|
May 23
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
412
-0.31%
|
$48,616
$118.65 P/Share
|
May 22
2023
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Open market or private sale
|
Direct |
2,400
-3.11%
|
$280,800
$117.58 P/Share
|
May 18
2023
|
Nicholas Augustinos Director |
BUY
Bona fide gift
|
Indirect |
3,976
+9.47%
|
-
|
May 18
2023
|
Nicholas Augustinos Director |
SELL
Bona fide gift
|
Direct |
3,976
-56.65%
|
-
|
May 18
2023
|
Nicholas Augustinos Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,043
+30.24%
|
-
|
May 18
2023
|
Steven R Altman Director |
BUY
Bona fide gift
|
Indirect |
3,916
+5.88%
|
-
|
May 18
2023
|
Steven R Altman Director |
SELL
Bona fide gift
|
Direct |
3,916
-57.58%
|
-
|
May 18
2023
|
Steven R Altman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,885
+29.79%
|
-
|
May 18
2023
|
Jay S Skyler Director |
BUY
Bona fide gift
|
Indirect |
3,876
+5.77%
|
-
|
May 18
2023
|
Jay S Skyler Director |
SELL
Bona fide gift
|
Direct |
3,876
-100.0%
|
-
|
May 18
2023
|
Karen M Dahut Director |
BUY
Bona fide gift
|
Indirect |
3,948
+26.92%
|
-
|
May 18
2023
|
Karen M Dahut Director |
SELL
Bona fide gift
|
Direct |
3,948
-47.01%
|
-
|
May 18
2023
|
Karen M Dahut Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,906
+25.71%
|
-
|
May 18
2023
|
Eric Topol Director |
BUY
Bona fide gift
|
Indirect |
3,952
+1.04%
|
-
|
May 18
2023
|
Eric Topol Director |
SELL
Bona fide gift
|
Direct |
3,952
-57.58%
|
-
|
May 18
2023
|
Eric Topol Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,911
+29.78%
|
-
|
May 18
2023
|
Kyle Malady Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,885
+15.67%
|
-
|
May 18
2023
|
Barbara Kahn Director |
BUY
Bona fide gift
|
Indirect |
3,976
+16.83%
|
-
|
May 18
2023
|
Barbara Kahn Director |
SELL
Bona fide gift
|
Direct |
3,976
-57.6%
|
-
|
May 18
2023
|
Barbara Kahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,927
+29.78%
|
-
|
May 18
2023
|
Bridgette P Heller Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,911
+10.69%
|
-
|
May 18
2023
|
Mark G Foletta Director |
BUY
Bona fide gift
|
Indirect |
4,488
+7.06%
|
-
|
May 18
2023
|
Mark G Foletta Director |
SELL
Bona fide gift
|
Direct |
4,488
-57.58%
|
-
|
May 18
2023
|
Mark G Foletta Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,306
+29.78%
|
-
|
May 18
2023
|
Richard Alexander Collins Director |
BUY
Bona fide gift
|
Indirect |
3,948
+9.78%
|
-
|
May 18
2023
|
Richard Alexander Collins Director |
SELL
Bona fide gift
|
Direct |
3,948
-57.6%
|
-
|
May 18
2023
|
Richard Alexander Collins Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,906
+29.77%
|
-
|
May 09
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
393
-0.47%
|
$47,160
$120.19 P/Share
|
Apr 27
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
5,031
-3.65%
|
$633,906
$126.0 P/Share
|
Apr 24
2023
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
412
-0.3%
|
$51,088
$124.68 P/Share
|
Apr 20
2023
|
Jacob Steven Leach EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,764
-10.59%
|
$3,845,500
$125.0 P/Share
|
Apr 20
2023
|
Shelly Ramasamy Selvaraj SVP Chief Information Officer |
SELL
Open market or private sale
|
Direct |
2,007
-3.68%
|
$250,875
$125.0 P/Share
|
Apr 20
2023
|
Barry J. Regan EVP Operations |
SELL
Open market or private sale
|
Direct |
2,214
-3.14%
|
$274,536
$124.5 P/Share
|
Apr 17
2023
|
Paul R Flynn EVP Global Revenue |
SELL
Open market or private sale
|
Direct |
2,781
-5.07%
|
$333,720
$120.0 P/Share
|
Apr 10
2023
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
393
-0.47%
|
$44,016
$112.35 P/Share
|
Apr 03
2023
|
Michael Jon Brown EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,612
-1.86%
|
$415,380
$115.06 P/Share
|
Apr 03
2023
|
Kevin R Sayer President CEO and Chairman |
SELL
Open market or private sale
|
Direct |
20,812
-2.03%
|
$2,372,568
$114.64 P/Share
|